Cargando…
Active surveillance in low risk papillary thyroid carcinoma
In recent decades, while the incidence of thyroid cancer has increased exponentially around the world, mortality has remained stable. The vast majority of this increase is attributable to the identification of intrathyroidal papillary microcarcinomas, which exhibit slow growth rates with indolent co...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450818/ https://www.ncbi.nlm.nih.gov/pubmed/32874948 http://dx.doi.org/10.5306/wjco.v11.i6.320 |
_version_ | 1783574868175880192 |
---|---|
author | Pitoia, Fabian Smulever, Anabella |
author_facet | Pitoia, Fabian Smulever, Anabella |
author_sort | Pitoia, Fabian |
collection | PubMed |
description | In recent decades, while the incidence of thyroid cancer has increased exponentially around the world, mortality has remained stable. The vast majority of this increase is attributable to the identification of intrathyroidal papillary microcarcinomas, which exhibit slow growth rates with indolent courses. A diagnosis of thyroid cancer based upon the presence of these small tumors could be considered as an overdiagnosis, as the majority of these tumors would not likely result in death if left untreated. Although surgical resection was the classical standard therapy for papillary microcarcinomas, active surveillance (AS) has emerged over the last three decades as an alternative approach that is aimed to recognize a minority group of patients who will clinically progress and would likely benefit from rescue surgery. Despite the encouraging results of AS, its implementation in clinical practice is strongly influenced by psychosocial factors. The aim of this review is to describe the epidemiology, clinical evolution, prognostic factors, and mortality of papillary thyroid microcarcinomas. We also summarize the AS strategy according to published evidence, characterize the criteria for selecting patients for AS according to risk factors and environmental characteristics, as well as analyze the current limitations for AS implementation. |
format | Online Article Text |
id | pubmed-7450818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-74508182020-08-31 Active surveillance in low risk papillary thyroid carcinoma Pitoia, Fabian Smulever, Anabella World J Clin Oncol Review In recent decades, while the incidence of thyroid cancer has increased exponentially around the world, mortality has remained stable. The vast majority of this increase is attributable to the identification of intrathyroidal papillary microcarcinomas, which exhibit slow growth rates with indolent courses. A diagnosis of thyroid cancer based upon the presence of these small tumors could be considered as an overdiagnosis, as the majority of these tumors would not likely result in death if left untreated. Although surgical resection was the classical standard therapy for papillary microcarcinomas, active surveillance (AS) has emerged over the last three decades as an alternative approach that is aimed to recognize a minority group of patients who will clinically progress and would likely benefit from rescue surgery. Despite the encouraging results of AS, its implementation in clinical practice is strongly influenced by psychosocial factors. The aim of this review is to describe the epidemiology, clinical evolution, prognostic factors, and mortality of papillary thyroid microcarcinomas. We also summarize the AS strategy according to published evidence, characterize the criteria for selecting patients for AS according to risk factors and environmental characteristics, as well as analyze the current limitations for AS implementation. Baishideng Publishing Group Inc 2020-06-24 2020-06-24 /pmc/articles/PMC7450818/ /pubmed/32874948 http://dx.doi.org/10.5306/wjco.v11.i6.320 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Pitoia, Fabian Smulever, Anabella Active surveillance in low risk papillary thyroid carcinoma |
title | Active surveillance in low risk papillary thyroid carcinoma |
title_full | Active surveillance in low risk papillary thyroid carcinoma |
title_fullStr | Active surveillance in low risk papillary thyroid carcinoma |
title_full_unstemmed | Active surveillance in low risk papillary thyroid carcinoma |
title_short | Active surveillance in low risk papillary thyroid carcinoma |
title_sort | active surveillance in low risk papillary thyroid carcinoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450818/ https://www.ncbi.nlm.nih.gov/pubmed/32874948 http://dx.doi.org/10.5306/wjco.v11.i6.320 |
work_keys_str_mv | AT pitoiafabian activesurveillanceinlowriskpapillarythyroidcarcinoma AT smuleveranabella activesurveillanceinlowriskpapillarythyroidcarcinoma |